Brazil vs Central African Republic: Paying taxes: Postfiling index (0-100) (DB17-20 methodology) - Score
Brazil
7.8
in 2019
Central African Republic
5.13
in 2019
Brazil rank
177th
Central African Republic rank
178th
Paying taxes: Postfiling index (0-100) (DB17-20 methodology) - Score over time
- Brazil
- Central African Republic
How they compare
Brazil currently reports 7.8 against 5.13 in Central African Republic, a difference of 2.67.
That makes Brazil's figure about 1.5 times Central African Republic's.
Across all 5 years both countries report, Brazil has been ahead every year.
Brazil ranks 177th and Central African Republic ranks 178th of 182 countries.
Brazil has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher paying taxes: postfiling index (0-100) (db17-20 methodology) - score, Brazil or Central African Republic?
- Brazil, at 7.8 against 5.13 in Central African Republic as of 2019.
- What is the difference in paying taxes: postfiling index (0-100) (db17-20 methodology) - score between Brazil and Central African Republic?
- 2.67, with Brazil ahead.
- How many years of comparable data are there for Brazil and Central African Republic?
- 5 years are reported by both, from 2015 to 2019.
- How do Brazil and Central African Republic rank globally for paying taxes: postfiling index (0-100) (db17-20 methodology) - score?
- Brazil ranks 177th and Central African Republic ranks 178th of 182 countries.
- Where does this data come from?
- The World Bank, published as Paying taxes: Postfiling index (0-100) (DB17-20 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for postfiling index benchmarks economies with respect to the regulatory best practice on the indicator. The score is indicated on a scale from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB17-20 studies.